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Abstract 
Avian leukosis virus (ALV) is a retrovirus that causes tumors in avian species, and its vertical and horizontal transmis-
sion in poultry flocks results in enormous economic losses. Despite the discovery of specific host receptors, there have 
been few reports on the modulation of viral susceptibility via genetic modification. We therefore engineered acquired 
resistance to ALV subgroup B using CRISPR/Cas9-mediated genome editing technology in DF-1 chicken fibroblasts. 
Using this method, we efficiently modified the tumor virus locus B (tvb) gene, encoding the TVB receptor, which is 
essential for ALV subgroup B entry into host cells. By expanding individual DF-1 clones, we established that artifi-
cially generated premature stop codons in the cysteine-rich domain (CRD) of TVB receptor confer resistance to ALV 
subgroup B. Furthermore, we found that a cysteine residue (C80) of CRD2 plays a crucial role in ALV subgroup B entry. 
These results suggest that CRISPR/Cas9-mediated genome editing can be used to efficiently modify avian cells and 
establish novel chicken cell lines with resistance to viral infection.
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and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
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Introduction
Avian leukosis virus (ALV) is a retrovirus that infects 
avian species, eventually causing tumors [1]. The ALV is 
a group VI virus of the family Retroviridae, and it can be 
divided into six subgroups, A–E and J, based on retroviral 
envelope glycoproteins that play a crucial role in host–
virus interactions [2]. ALV-infected poultry display sev-
eral symptoms, including lymphoblastic, erythroblastic 
and osteopetrotic tumors, and the virus can be transmit-
ted both vertically and horizontally. The spread of ALV 
in poultry flocks therefore causes tremendous economic 
losses within the poultry industry [3].
Susceptibility and resistance to the virus depend largely 
on specific host receptors that interact with viral enve-
lope proteins. Naturally occurring genetic mutations 
in the host receptors, or artificial expression of mutant 
receptors in host cells, can affect susceptibility to the 
virus. A four base pair (bp) insertion and 1 bp substitu-
tion in the tumor virus locus A (tva) gene confer resist-
ance to ALV subgroup A [4], and mutations in the first 
intron of tva are also reported to reduce susceptibility to 
ALV subgroup A [5, 6]. Chickens with a 1 bp substitution 
in tvb creating an in-frame stop codon exhibit complete 
resistance to ALV subgroup B, and a single amino acid 
substitution (C125S) reduces susceptibility to ALV sub-
groups B, D and E [7, 8]. Resistance to ALV subgroup C is 
closely related to a 1 bp substitution in tumor virus locus 
C (tvc) that creates an in-frame stop codon [9]. Moreover, 
comparative studies suggest that variation in tryptophan 
38 (W38) in the NHE1 gene explains the differences in 
susceptibility to ALV subgroup J among avian species 
[10, 11].
Despite the discovery of specific host receptors that 
are critical for ALV entry, there has been only one report 
on the acquisition of resistance to ALV subgroup C in 
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avian species via genome editing of host receptor genes. 
This can be attributed partly to the lack of an efficient 
genome editing technology [9]. The recently developed 
clustered regularly interspaced short palindromic repeats 
(CRISPR)/CRISPR-associated (Cas9) system is a pro-
grammable genome editing technology [12] that has been 
widely adopted for use in many organisms, including 
mice, fish, pigs and cows [13–16]. Among avian species, 
CRISPR/Cas9 has also been used successfully for genome 
editing in chickens [17, 18].
We performed genome editing on the chicken host 
receptor gene tvb, which is related specifically to ALV 
subgroup B. Since chickens with premature stop codons 
in CRDs of TVB receptors exhibit resistance to ALV 
subgroup B, we sought to identify artificial mutations in 
CRDs of TVB receptors that cause similar effects [7]. We 
adopted the CRISPR/Cas9 system, an efficient program-
mable genome editing tool, for use in DF-1 chicken fibro-
blasts. We then evaluated the susceptibility of genetically 
modified hosts to ALV subgroup B using flow cytometry.
Materials and methods
Experimental animals and animal care
The care and experimental use of chickens were approved 
by the Institute of Laboratory Animal Resources, Seoul 
National University (SNU-150827-1). Chickens were 
maintained according to a standard management pro-
gram at the University Animal Farm, Seoul National Uni-
versity, Korea. The procedures for animal management, 
reproduction and embryo manipulation adhered to the 
standard operating protocols of our laboratory.
Construction of CRISPR/Cas9 expression vectors
We constructed all-in-one CRISPR/Cas9 vectors target-
ing tvb, with minor modifications. The CRISPR kit used 
for constructing multiplex CRISPR/Cas9 vectors was a 
gift from Takashi Yamamoto (Addgene Kit #1000000054) 
[19], and a neomycin resistance gene under the regula-
tion of a thymidine kinase promoter was inserted into 
CRISPR/Cas9 vectors by NotI digestion and ligation 
(New England Biolabs, Ipswich, MA, USA). For the inser-
tion of guide RNA sequences into CRISPR/Cas9 vectors, 
we synthesized sense and antisense oligonucleotides 
(Bionics, Seoul, Korea) and carried out annealing using 
the following thermocycling conditions: 30  s at 95  °C, 
2 min at 72  °C, 2 min at 37  °C and 2 min at 25  °C. The 
oligonucleotides used are listed in Table 1.
Culture of DF‑1 chicken fibroblasts
DF-1 cells were maintained and subpassaged in Dul-
becco’s minimum essential medium (DMEM; Hyclone, 
Logan, UT, USA), supplemented with 10% fetal bovine 
serum (FBS; Hyclone) and 1× antibiotic–antimycotic 
(ABAM; Thermo Fisher–Invitrogen, Carlsbad, CA, USA). 
DF-1 cells were cultured in an incubator at 37  °C in an 
atmosphere of 5%  CO2 at 60–70% relative humidity.
Culture of White Leghorn (WL) chicken embryonic 
fibroblasts (CEFs)
All internal organs and limbs were removed from WL 
chicken embryos of 6-day-incubated fertilized eggs, and 
the remaining embryonic body was then dissociated 
using 0.05% (v/v) trypsin/ethylenediaminetetraacetic acid 
(Gibco, Grand Island, NY, USA) at 37 °C for 15 min. The 
limbs were used for genomic DNA extraction, and the 
dissociated cells were filtered through 70 mm nylon mesh 
filters and cultured in DMEM (Hyclone) containing 10% 
FBS (Hyclone) and 1% ABAM (Thermo Fisher–Invitro-
gen) in a 5%  CO2 atmosphere at 37 °C [20].
Transfection and G418 selection of DF‑1 cells
CRISPR/Cas9 vectors (3  µg) were mixed with Lipo-
fectamine 2000 reagent (Thermo Fisher–Invitrogen) in 
Opti-MEM (Thermo Fisher–Invitrogen), and the mixture 
was applied to 5 × 105 DF-1 cells. Then, 6 h after trans-
fection, transfection mixtures were replaced with DF-1 
culture medium. Geneticin® Selective Antibiotic (G418; 
GIBCO Invitrogen, Grand Island, NY, USA) (300 µg/mL) 
was added to the culture medium 1 day after transfection. 
The complete selection period required up to 7 days.
T7E1 assay
We adapted the T7E1 assay method from previous 
publications with minor modifications [21]. Genomic 
DNA was extracted from DF-1 cells after G418 selec-
tion. Genomic regions encompassing the CRISPR/Cas9 
target sites were amplified using specific primer sets 
(Table  1). The amplicons were reannealed to form a 
heteroduplex DNA structure after denaturation. Subse-
quently, the heteroduplex amplicons were treated with 
5 units T7E1 endonuclease (New England Biolabs) for 
Table 1 Primers used in this study
Primers Sequence
TVB #1 F 5′- CAC CGG CAG CTG AGC GCA TCG TGC G -3′
TVB #1 R 5′- AAA CCG CAC GAT GCG CTC AGC TGC C -3′
TVB #2 F 5′- CAC CGA ATG ACT TTC CCA AGT GCC T -3′
TVB #2 R 5′- AAA CAG GCA CTT GGG AAA GTC ATT C -3′
TVB #1 seq F 5′- AGC TGT CAG CTG GTG GAG TTC AC -3′
TVB #1 seq R 5′- ATA GCG TCC AAT CTG GGT GAG CC -3′
TVB #2 seq F 5′- TCT CCA CGT CTC GGC AGC AC -3′
TVB #1 seq R 5′- CAG CTC TGC TCG GGC TCT CC -3′
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20  min at 37  °C and then analyzed by 1% agarose gel 
electrophoresis.
Culture of single DF‑1 cells and genomic DNA sequencing
After G418 selection, single DF-1 cells from the DF-1 
cells treated with CRISPR vectors were seeded in individ-
ual wells of a 96-well plate with 100 µL culture medium. 
We checked the wells each day after seeding and, when 
the cells in each well were confluent, subpassaged the 
cells into a 48-well plate. These cells were then used for 
genomic DNA extraction. The genomic regions encom-
passing the CRISPR/Cas9 target sites in DF-1 and WL 
CEFs were amplified using specific primer sets (Table 1), 
and the PCR products were sequenced using the ABI 
Prism 3730 XL DNA Analyzer (Thermo Fisher–Applied 
Biosystems, Foster City, CA, USA). The sequences were 
analyzed against assembled genomes using BLAST 
(http://blast.ncbi.nlm.nih.gov).
Virus production and infection
RCASBP-(B)-CN-EGFP was kindly provided by Dr. Yao 
and Dr. Nair (Pirbright Institute). CRISPR/Cas9 vec-
tors (5  µg) were mixed with Lipofectamine 2000 rea-
gent (Thermo Fisher–Invitrogen) in Opti-Mem (Thermo 
Fisher–Invitrogen), and the mixture was applied to 
1 × 106 DF-1 cells. The mixture was replaced with DF-1 
culture medium 6  h after transfection. One day after 
transfection we could detect green fluorescence in DF-1 
cells, which indicated virus production. Cells were sub-
passaged, and the medium was changed 1 day after sub-
passaging. One day later, the medium containing virus 
was harvested and frozen at −70  °C until use. For viral 
infection, the medium containing virus was thawed at 
37 °C and added to individual DF-1 and WL CEF clones. 
Four days post-infection, DF-1 and WL CEFs were 
observed using fluorescence microscopy (TU-80; Nikon, 
Tokyo, Japan) and analyzed using FACSCalibur (BD Bio-
sciences, San Jose, CA, USA).
Protein alignment and structure analysis
The protein sequences and bisulfide bond structures 
of human DR5 TRAIL receptor (NP_003833.4), mouse 
Tnfrsf10b (NP_064671.2), western clawed frog tnfrsf10b 
(NP_001004894.1), chicken  TVBS1 (NP_989446.2) and 
chicken  TVBS3 were analyzed using ClustalW.
Statistical analysis
Statistical analysis system (SAS) software was used for 
analysis of ALV subgroup B susceptibility. Each treatment 
was compared using the least-squares method or Dun-
can’s method, and the significance of the main effects was 
determined using analysis of variance in the SAS package. 
A p value < 0.05 was regarded as statistically significant.
Results
Virus production in DF‑1 cells
To produce ALV subgroup B in chicken DF-1 cells, cells 
were transfected with the RCASBP-(B)-CN-EGFP vector. 
This vector contains a green fluorescent protein (GFP)-
expressing cassette with ALV subgroup B gag, env and pol 
genes (Figure 1A). This allowed us to assess virus produc-
tion in DF-1 cells based on GFP expression compared 
with wild type (WT) DF-1 cells (Figure 1B).
Genome editing in tvb mediated by CRISPR/Cas9
To efficiently disrupt tvb, we designed two CRISPR/Cas9 
vectors targeting two different sites within the gene. The 
TVB#1 vector (TVB#1) was designed to target the ATG 
sequence of tvb, which can inhibit gene translation. The 
TVB#2 vector (TVB#2) was designed to target exon 3 
of tvb, which can cause frame shift mutations resulting 
in production of a stop codon in CRDs of TVB recep-
tors [7] (Figure  2A). DF-1 cells transfected with TVB#1 
and TVB#2 were successfully selected 7 days post-trans-
fection using G418, and T7E1 analysis showed that the 
transfected cells had indel mutations in targeted loci 
(Figure  2B). The mutations were analyzed using the TA 
cloning method, and the mutation efficiencies of the two 
targeted loci were 70 and 45.5% in DF-1 cells transfected 
with TVB#1 and TVB#2, respectively (Figure  2C). The 
patterns of mutations were diverse in both experimen-
tal groups. In DF-1 cells transfected with TVB#1, we 
identified both deletions and insertions. In DF-1 cells 
transfected with TVB#2, only deletions mutations were 
identified (Figure 2C).
Establishment of single DF‑1 clones and genomic DNA 
analysis
To establish single tvb-mutated DF-1 clones, we picked 
single cells from DF-1 cells transfected with TVB#1 and 
TVB#2, respectively. The picked single cells became 
attached and actively proliferated (Additional file  1: 
A). We established several different clones from both 
TVB#1- and TVB#2- transfected DF-1 cells. Unfortu-
nately, we obtained only clones with a 1  bp insertion 
before the ATG sequence from DF-1 cells transfected 
with TVB#1 (Additional file  2); therefore, we evalu-
ated only the clones from DF-1 cells transfected with 
TVB#2. For 3‒4 weeks, a total of 21 clones from DF-1 
cells transfected with TVB#2 were established (Addi-
tional file  1: B), and the clones were then sequenced. 
Sequencing of the PCR products revealed a single clear 
peak in all samples, indicating that all DF-1 clones had 
diverse bi-allelic mutation patterns (Table  2; Addi-
tional file 3). Specifically, clone #17 had a 44 bp inser-
tion in targeted loci, and clones #13, #16 and #28 had 
15, 12 and 15  bp deletions, respectively, which could 
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not induce frame shift mutations. Other clones (#2, 
#10, #14, #18, #19, #21, #23, #25 and #27) had dele-
tions in targeted loci that caused frame shift mutations 
(Table 2).
ALV subgroup B infection in single DF‑1 clones and flow 
cytometry
To verify the susceptibility of DF-1 clones to ALV sub-
group B infection, clones from DF-1 cells transfected with 
Figure 1 Schematic representation of this study and virus production in DF-1 cells by RCAS vectors. A Overview of this study. The 
CRISPR/Cas9 vectors including Cas9 protein-coding sequences, tvb-targeting guide RNA and neomycin resistance genes were transfected into DF-1 
cells. After G418 selection, T7E1 assays and TA cloning were performed. tvb-modified single DF-1 cells were cultured in 96-well plates, and tvb from 
individual DF-1 clones was sequenced. Clones were infected with ALV subgroup B produced by RCASBP-(B)-CN-EGFP vector-transfected DF-1 cells. 
B ALV subgroup B production in DF-1 cells. DF-1 cells transfected with RCASBP-(B)-CN-EGFP vectors expressed green fluorescent protein (GFP). 
Non-transfected DF-1 cells (WT) used as negative control. Scale bar = 200 µm.
Figure 2 Genetic modification of tvb by CRISPR/Cas9 in DF-1 cells. A Gene structure of tvb (TNFRSF10B) and recognition sites of TVB#1 and 
TVB#2 CRISPR/Cas9 vectors. Blue bars indicate guide RNA recognition sites, and red bars indicate protospacer-adjacent motif (PAM) sequences. 
Scale bar = 1 kb. B T7E1 assay for DF-1 cells transfected with TVB#1 and TVB#2 CRISPR/Cas9 vectors. Bands cleaved by T7E1 endonuclease were 
seen in the experimental groups. C Sequencing analysis of transfected DF-1 cells using the TA cloning method. Grey letters indicate insertions, and 
grey letters with lines indicate deletions. Indel mutations and their frequencies are presented. Blue bars indicate guide RNA recognition sites, and 
red bars indicate PAM sequences. Wild type (WT) DF-1 cells were used as the control.
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Underlining indicates the TVB#2 guide RNA recognition site and protospacer-adjacent motif (PAM) 
sequences
Strikethrough lines indicate deleted nucleotides and lowercase letters indicate inserted nucleotides
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TVB#2 were infected with ALV subgroup B. Strong GFP 
expression was detected in nine different clones (#1, #3, 
#7, #9, #11, #12, #16, #20 and #24) compared with WT 
DF-1 cells at 4 days post-infection. We also found mark-
edly lower levels of GFP expression in clones #2, #10, #14, 
#17, #18, #19, #21, #23, #25 and #27 and moderate levels 
of GFP expression in clones #13 and #28 (Figure 3A). The 
results of flow cytometric analysis showed that the pro-
portions of GFP-expressing cells in DF-1 clones #1, #3, 
#7, #9, #11, #12, #16, #20 and #24 were 82.6, 93.8, 96.1, 
Figure 3 Viral infection of DF-1 clones and flow cytometric analysis. A GFP expression in virus-infected DF-1 cells. Twenty-one DF-1 clones 
were evaluated under a fluorescence microscope. Scale bar = 200 µm. B, C Flow cytometric analysis of virus-infected DF-1 clones. WT DF-1 cells 
were used as the control.
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87.9, 98.7, 97.6, 91.8, 97.1 and 85.8%, respectively. The 
proportions of GFP-expressing cells in clones #2, #10, 
#14, #17, #18, #19, #21, #23, #25 and #27, which exhibited 
low levels of GFP expression, were 9.3, 5.9, 10.9, 8.3, 13.1, 
12.8, 6.5, 6.5, 6.7 and 6.2%, respectively. The proportions 
of GFP-expressing cells in clones #13 and #28, which 
exhibited moderate levels of GFP expression, were 53.3 
and 49.2%, respectively (Figures 3B and C).
Amino acid sequence analysis
To identify the reason for the significantly reduced ALV 
group B susceptibility in tvb-mutated DF-1 clones, we 
analyzed their amino acid sequences. First, we com-
pared the sequence of tumor necrosis factor receptor 
superfamily member 10B (TNFRSF10B) among humans, 
mice, frogs and chickens  (TVBS1 and  TVBS3). Sequence 
alignment analysis revealed highly conserved amino acid 
sequences in CRDs located in the extracellular recep-
tor domain and cytoplasmic death domain (DD), which 
mediates the apoptosis signaling pathway. In particular, 
we located highly conserved cysteine residues in CRDs 
that formed bisulfide bonds (Figure 4A).
Next, we deduced the amino acid sequences of tvb-
mutated DF-1 clones. Amino acid sequence analysis 
showed that clones #10, #14 and #18 shared the same 
amino acid sequences, as did clones #21, #23 and #25. 
Clones had mutations that generated an in-frame stop 
codon resulting in the production of a truncated pro-
tein similar to that of the WT tvbr. Clones #13 and #28, 
which expressed moderate levels of GFP, possessed the 
same mutations, including five amino acid deletions and 
one amino acid substitution from the  77th to  82nd amino 
acid positions of the TVB receptor. Clone #16, which 
expressed high levels of GFP, had four amino acids dele-
tions from the 76th to 79th amino acid positions of the 
TVB receptor (Figure 4B). The mutations of nucleotides 
and deduced amino acids, and results of virus challenge 
in tvb-modified DF-1 clones were summarized in Table 3.
Discussion
The acquisition of complete disease resistance is the ulti-
mate goal of the agricultural industry and human soci-
ety. However, despite the development of vaccines and 
improvements in quarantine facilities, complete disease 
control is elusive owing to economic costs and the rapid 
evolution of viruses. To overcome these limitations, tar-
geted DNA modification using CRISPR/Cas9 technology 
has been used against a variety of viruses [22–27]. This 
system specifically targets and modifies the structure of 
viral genomes or host viral receptor genes and may there-
fore be used for efficient viral disease prevention without 
off-target events [28]. Therefore, in the present study, 
we used the CRISPR/Cas9-mediated genome editing 
method to confer resistance to ALV subgroup B in DF-1 
chicken fibroblasts.
To evaluate the feasibility of CRISPR/Cas9-mediated 
genome editing for engineering resistance to ALV sub-
group B, we first designed two CRISPR/Cas9 vectors 
Figure 4 Analysis of deduced amino acid sequences of tvb-modified DF-1 clones. A Sequence alignment of human DR5 TRAIL receptor 
(NP_003833.4), mouse Tnfrsf10b (NP_064671.2), western clawed frog tnfrsf10b (NP_001004894.1) and chicken  TVBS1 (NP_989446.2). Blue boxes indi-
cate cysteine-rich domains (CRDs) and death domains (DDs); shaded boxes indicated similarities among amino acid sequences. Asterisks indicate 
conserved cysteine residues. B Sequence alignment of deduced amino acids in tvb-modified DF-1 clones. Red boxes indicate conserved cysteine 
residues, and numbers indicate the order of the amino acids in TVB proteins. Asterisks indicate stop codons. WT with tvbs1, tvbs3 and tvbr genotypes 
were used as the control.
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specifically targeting two tvb loci for genetic mutations 
(Figure  2A). Chickens that have a naturally occur-
ring single bp mutation in tvb are reported to be resist-
ant to infection by ALV subgroups B, D and E, and this 
is thought to be because of the creation of a premature 
stop codon in the CRD1 domain [7]. To artificially gener-
ate a premature stop codon in tvb in DF-1 cells, we tar-
geted the 3’ region of the CRD1 coding region. We also 
targeted the tvb start codon to achieve total disruption of 
tvb receptor protein production. We found that targeted 
loci were successfully modified to possess indel muta-
tions, and most mutations occurred in regions neigh-
boring protospacer-adjacent motif sequences, which is 
consistent with previous research (Figure 2C) [17].
Next, we cultured DF-1 clones harboring tvb mutations 
to obtain clones with homozygous genotypes (Additional 
file  1). To avoid misinterpretation due to mixed geno-
types during the virus challenge experiment, we verified 
DF-1 genotypes by sequencing analysis of PCR products. 
In total, 21 single DF-1 clones from TVB#2-transfected 
DF-1 cells were established. Of these, 12 had indel muta-
tions in tvb, of which 11 were deletions, and only 1 was an 
insertion (Table 2). As previous research has reported, our 
results showed that the deletions were mostly CRISPR/
Cas9-mediated mutations [29]. Sequencing analysis 
showed that all DF-1 clones had bi-allelic mutations, which 
was also consistent with previous research (Additional files 
2 and 3) [30, 31]. However, using TVB#1 we were able to 
obtain only DF-1 clones that had 1 bp insertions in the 5’ 
region (see Additional file  2). The sequencing results for 
TVA#1-transfected DF-1 cells suggested that more clones 
were required for analysis or that precise genome editing 
mediated by homologous recombination was required to 
obtain clones with mutations in ATG sequences.
To evaluate the viral susceptibility of established single 
DF-1 cells, the cells were infected with ALV subgroup B 
produced by replication-competent ALV long terminal 
repeat (LTR) using a splice acceptor (RCAS) vector. The 
RCAS vector used in the present study is replication-
competent in avian cells, and the vector spreads rapidly 
and infects most cells in  vitro within a short period of 
time [32]. Exploiting these characteristics, we suc-
cessfully produced ALV subgroup B in DF-1 cells (Fig-
ure 1B). In the virus challenge experiments, single DF-1 
clones with mutations (#2, #10, #13, #14, #17, #18, #19, 
#21, #22, #23, #25, #27 and #28) had significantly lower 
levels of GFP expression compared with WT DF-1 cells. 
This suggests that genetic modification of tvb affected 
ALV subgroup B susceptibility in DF-1 cells. However, in 
this paper, we could not get the absolute resistant against 
to ALV subgroup B. 5.9% (#10) was the least expression 
of GFP among the clones (Figure  3C). The results may 
come from different between genotype of chicken that 
has tvbr and those of tvb-modified DF-1 clones. Analysis 
of deduced amino acid shows tvb-modified DF-1 clones 
have still 59th cysteine residue that is important in ALV 
subgroup B entry [7]. Precise modification of the DF-1 
tvb gene to tvbr genotypes may cause absolute resistant 
to the virus. Furthermore, the results can come from dif-
ference between in  vivo and in  vitro system. Previous 
report revealed that the chickens that have resistant to 
ALV subgroup A do not have any proliferation of sarco-
mas even after 42 dpi even 40% of their CEF express GFP 
at 7  dpi by ALV subgroup A infection [6]. The results 
suggest that there is difference between in  vivo and 
in  vitro validation. To identify resistance to ALV sub-
group B, genome-edited chicken needs to be produced 
and validated comparing with the chickens that have tvbr 
genotype.
Analysis of deduced amino acid sequences revealed 
that genetic modifications of tvb generated a premature 
stop codon in the CRD2 domain (Figure  4B). This sug-
gested that the artificially generated stop codon plays a 
crucial role in ALV subgroup B entry into host cells, simi-
lar to virus-resistant WL CEFs [7]. Resistance to human 
immunodeficiency virus (HIV) infection is also associ-
ated with mutations in a host receptor, CCR5. Individuals 
who have a 32 bp deletion that creates a premature stop 
codon in the CCR5 receptor are resistant to HIV [33, 34]. 
Therefore, our results support the notion that amino acid 
substitutions, particularly those that generate premature 
stop codons in host receptors, can abolish the functions 
of these receptors in viral interactions.
Table 3 Mutations of nucleotides and deduced amino 
acids, and results of virus challenge in tvb-modified DF-1 
clones
ID Indel Amino acid mutation GFP expression (%)
WT WT No mutation Strong (92.6)
#16 −12 bp 4 amino acid deletion (76th to 
79th positions)
Strong (91.8)
#13 −15 bp 5 amino acid deletion (77th to 
80th positions)
Moderate (53.3)
#28 −15 bp 5 amino acid deletion (77th to 
80th positions)
Moderate (49.2)
#19 −26 bp Premature stop codon Low (12.8)
#17 +44 bp Premature stop codon Low (8.3)
#27 −17 bp Premature stop codon Low (6.2)
#2 −11 bp Premature stop codon Low (9.3)
#10 −8 bp Premature stop codon Low (5.9)
#14 −8 bp Premature stop codon Low (10.9)
#18 −8 bp Premature stop codon Low (13.1)
#21 −7 bp Premature stop codon Low (6.5)
#23 −7 bp Premature stop codon Low (6.5)
#25 −7 bp Premature stop codon Low (6.7)
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Interestingly, DF-1 clone #16 contained 91.8% GFP-
expressing cells, although tvb gene contained a 12  bp 
deletion. This suggests that the deletion of four amino 
acids from the  76th to  79th positions of the TVB receptor 
does not significantly alter viral susceptibility. Compar-
ing this clone with clones #13 and #28, which possessed 
a 15  bp deletion, suggested that cysteine 80 and argi-
nine 81 within the TVB receptor play an important 
role in ALV subgroup B entry into host cells. Indeed, 
cysteine residues in CRDs are crucial for viral entry in 
several organisms. For example, the attachment of her-
pes simplex virus (HSV), equine infectious anemia virus 
(EIAV), feline immunodeficiency virus (FIV) and rabies 
virus (RABV) to host cells is mediated by the CRDs of 
their specific TNF receptors (herpes virus entry media-
tor [TANFRSF14] for HSV and EIAV, Ox40 [CD134, 
TNFRSF4] for FIV and NTRp75 for RABV). Cysteine 
residues in these CRDs are highly conserved, and muta-
tions in these residues cause conformational changes in 
the extracellular regions of the receptors, altering their 
affinity to ligands [35]. In avian species, a cysteine-to-
tryptophan substitution in the low-density lipopro-
tein receptor-like region of TVA drastically reduces 
the binding affinity of ALV subgroup A; similarly, a 
cysteine-to-serine mutation at position 62 in the  TVBS3 
receptor reduces susceptibility to ALV subgroup E [4, 
36]. Collectively, the results of the present study and 
previous research suggest the importance of bisulfide 
bonds in CRDs mediated by cysteine residues. However, 
studies investigating the precise replacement of cysteine 
80 by homologous recombination are required to pro-
vide further support for our hypothesis.
Conclusion
In the present study, we demonstrated the feasibility of 
CRISPR/Cas9-mediated genome modification for engi-
neering resistance to ALV subgroup B. We efficiently 
modified DF-1 chicken fibroblasts using the CRISPR/
Cas9 system and confirmed that modified DF-1 cells 
acquired resistance to ALV subgroup B. These results 
indicate that generating premature stop codons in the 
CRDs of TVB receptors can alter viral susceptibility, and 
that cysteine residues forming bisulfide bonds in CRDs 
may play important roles in determining susceptibil-
ity to ALV subgroup B. Furthermore, our results show 
that the CRISPR/Cas9 system can be used to efficiently 
modify the avian genome and establish novel avian cell 
lines, including virus-resistant chicken cell lines, medi-
ated by primordial germ cells with germline competency. 
Furthermore, we expect that this system will facilitate the 
study of virus-host interactions not only in avian species 
but also in humans, for example, HIV and its relationship 
with the human CCR5 co-receptor [33, 34].
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